Trial intelligence / Profile preview

Intraoperative lidocaine infusion in non-metastatic cancer surgery

ACTRN12611001005943Phase 4Not yet recruiting

Sponsor
Palmerston North Hospital
Start
Oct 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of lidocaine in cancer (2 arms), sponsored by Palmerston North Hospital. Primary endpoint: Tumor recurrence. Planned start Oct 2011; status: not yet recruiting.

02

Drugs

lidocaine
03

Conditions

cancer

Beyond the preview

Go deeper on ACTRN12611001005943.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12611001005943.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call